Your browser doesn't support javascript.
loading
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Gerds, Aaron T; Gotlib, Jason; Ali, Haris; Bose, Prithviraj; Dunbar, Andrew; Elshoury, Amro; George, Tracy I; Gundabolu, Krishna; Hexner, Elizabeth; Hobbs, Gabriela S; Jain, Tania; Jamieson, Catriona; Kaesberg, Paul R; Kuykendall, Andrew T; Madanat, Yazan; McMahon, Brandon; Mohan, Sanjay R; Nadiminti, Kalyan V; Oh, Stephen; Pardanani, Animesh; Podoltsev, Nikolai; Rein, Lindsay; Salit, Rachel; Stein, Brady L; Talpaz, Moshe; Vachhani, Pankit; Wadleigh, Martha; Wall, Sarah; Ward, Dawn C; Bergman, Mary Anne; Hochstetler, Cindy.
Afiliación
  • Gerds AT; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Gotlib J; Stanford Cancer Institute.
  • Ali H; City of Hope National Medical Center.
  • Bose P; The University of Texas MD Anderson Cancer Center.
  • Dunbar A; Memorial Sloan Kettering Cancer Center.
  • Elshoury A; Roswell Park Comprehensive Cancer Center.
  • George TI; Huntsman Cancer Institute at the University of Utah.
  • Gundabolu K; Fred & Pamela Buffett Cancer Center.
  • Hexner E; Abramson Cancer Center at the University of Pennsylvania.
  • Hobbs GS; Massachusetts General Hospital Cancer Center.
  • Jain T; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Jamieson C; UC San Diego Moores Cancer Center.
  • Kaesberg PR; UC Davis Comprehensive Cancer Center.
  • Kuykendall AT; Moffitt Cancer Center.
  • Madanat Y; UT Southwestern Simmons Comprehensive Cancer Center.
  • McMahon B; University of Colorado Cancer Center.
  • Mohan SR; Vanderbilt-Ingram Cancer Center.
  • Nadiminti KV; University of Wisconsin Carbone Cancer Center.
  • Oh S; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
  • Pardanani A; Mayo Clinic Cancer Center.
  • Podoltsev N; Yale Cancer Center/Smilow Cancer Hospital.
  • Rein L; Duke Cancer Institute.
  • Salit R; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.
  • Stein BL; Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Talpaz M; University of Michigan Rogel Cancer Center.
  • Vachhani P; O'Neal Comprehensive Cancer Center at UAB.
  • Wadleigh M; Dana-Farber/Brigham and Women's Cancer Center.
  • Wall S; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
  • Ward DC; UCLA Jonsson Comprehensive Cancer Center; and.
  • Bergman MA; National Comprehensive Cancer Network.
  • Hochstetler C; National Comprehensive Cancer Network.
J Natl Compr Canc Netw ; 20(9): 1033-1062, 2022 09.
Article en En | MEDLINE | ID: mdl-36075392
The classic Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) consist of myelofibrosis, polycythemia vera, and essential thrombocythemia and are a heterogeneous group of clonal blood disorders characterized by an overproduction of blood cells. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for MPN were developed as a result of meetings convened by a multidisciplinary panel with expertise in MPN, with the goal of providing recommendations for the management of MPN in adults. The Guidelines include recommendations for the diagnostic workup, risk stratification, treatment, and supportive care strategies for the management of myelofibrosis, polycythemia vera, and essential thrombocythemia. Assessment of symptoms at baseline and monitoring of symptom status during the course of treatment is recommended for all patients. This article focuses on the recommendations as outlined in the NCCN Guidelines for the diagnosis of MPN and the risk stratification, management, and supportive care relevant to MF.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Policitemia Vera / Mielofibrosis Primaria / Trombocitemia Esencial / Trastornos Mieloproliferativos Tipo de estudio: Diagnostic_studies / Guideline Límite: Adult / Humans Idioma: En Revista: J Natl Compr Canc Netw Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Policitemia Vera / Mielofibrosis Primaria / Trombocitemia Esencial / Trastornos Mieloproliferativos Tipo de estudio: Diagnostic_studies / Guideline Límite: Adult / Humans Idioma: En Revista: J Natl Compr Canc Netw Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos